NADPH Inhibits [2Fe-2S] Cluster Protein Transfer from Diabetes Drug Target MitoNEET to an Apo-acceptor Protein
John A. Zuris(Howard Hughes Medical Institute), Patricia A. Jennings(University of San Diego), Tung A. Nguyen(University of California San Diego), Rachel Nechushtai(Hebrew University of Jerusalem), Syed S. Ali(University of California San Diego), Howard Yeh(Hospital de Santa Maria), Mark L. Paddock(University of California San Diego)
Cited by 40
Related Papers
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
|Nature Biotechnology|2014|1.5k
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
|Journal of Clinical Oncology|2011|1.3k
NEET Proteins: A New Link Between Iron Metabolism, Reactive Oxygen Species, and Cancer
|Antioxidants and Redox Signaling|2018|198
Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors
|Supportive Care in Cancer|2013|182
Redox-dependent gating of VDAC by mitoNEET
|Proceedings of the National Academy of Sciences|2019|140